eIF3 p110 Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF3 p110 monoclonal antibodies for research in understanding cellular processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF3 p110 is a key component of the eukaryotic translation initiation factor 3 (eIF3) complex, which plays a vital role in the initiation of protein synthesis. eIF3 p110 is essential for the recruitment of the ribosome to mRNA, influencing the regulation of gene expression and cellular growth. Understanding eIF3 p110 function is crucial for elucidating mechanisms of translation control and its implications in various diseases, including cancer. Researchers can explore protein-protein interactions and localization patterns of eIF3 p110 through multiple experimental approaches. Advanced visualization techniques enable detailed examination of eIF3 p110 distribution within cellular compartments. Multiple conjugation options, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), provide flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing understanding of translation regulation and disease mechanisms.